Literature DB >> 9224359

Urinary calcium oxalate saturation in healthy infants and children.

B Hoppe1, A Jahnen, D Bach, A Hesse.   

Abstract

PURPOSE: A number of factors influence the development of renal calculi, the most essential of which is the supersaturation of urine with lithogenic substances. Calcium oxalate stones occur most frequently in adult and pediatric patients with urolithiasis. Therefore, we established normal age and sex related data for urinary calcium oxalate saturation in infancy and childhood to allow a more specific prediction of the risk of (recurrent) stone disease.
MATERIALS AND METHODS: We collected 24-hour urine samples from 473 healthy infants and children without a history of renal stones. Urinary lithogenic and stone inhibitory substances were measured, and the urinary calcium oxalate saturation was calculated using a computer program.
RESULTS: Mean urinary calcium oxalate saturation was always higher in boys than in girls, which was significant in infancy (5.22 versus 2.03, p < 0.05) and at ages 7 to 9 years (8.84 versus 5.47, p < 0.05). The saturation first increased (p < 0.05) until age 7 to 9 years in boys and girls, and remained at high levels at ages 10 to 12 years (7.03 versus 5.49, p < 0.05 compared to infancy). Calcium oxalate saturation then decreased until adolescence when values were comparable to those of infancy (5.29 versus 3.35).
CONCLUSIONS: We recommend calculating urinary calcium oxalate saturation for diagnostic purposes as well as for therapy control. Normal age and sex related values must be considered.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9224359

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

Review 1.  Pediatric urolithiasis: etiology, specific pathogenesis and medical treatment.

Authors:  K Sarica
Journal:  Urol Res       Date:  2006-01-24

2.  Role of urinary supersaturation in the evaluation of children with urolithiasis.

Authors:  Marc B Lande; William Varade; Elif Erkan; Yvonne Niederbracht; George J Schwartz
Journal:  Pediatr Nephrol       Date:  2005-02-17       Impact factor: 3.714

3.  Enteric hyperoxaluria, recurrent urolithiasis, and systemic oxalosis in patients with Crohn's disease.

Authors:  Renate Hueppelshaeuser; Gerd E von Unruh; Sandra Habbig; Bodo B Beck; Stephan Buderus; Albrecht Hesse; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2012-02-25       Impact factor: 3.714

4.  Urinary oxalate excretion in urolithiasis and nephrocalcinosis.

Authors:  T J Neuhaus; T Belzer; N Blau; B Hoppe; H Sidhu; E Leumann
Journal:  Arch Dis Child       Date:  2000-04       Impact factor: 3.791

5.  Clinical course of pediatric urolithiasis: follow-up data in a long-term basis.

Authors:  Hakan Koyuncu; Faruk Yencilek; Sakip Erturhan; Bilal Eryildirım; Kemal Sarica
Journal:  Int Urol Nephrol       Date:  2010-06-20       Impact factor: 2.370

6.  Hypocitraturia as a risk factor for nephrocalcinosis after kidney transplantation.

Authors:  Ludwig Stapenhorst; Robert Sassen; Bodo Beck; Norbert Laube; Albrecht Hesse; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2005-03-22       Impact factor: 3.714

7.  Temporary risk identification in urolithiasis.

Authors:  Y M Fazil Marickar; Abiya Salim
Journal:  Urol Res       Date:  2009-10-15

8.  Hyperoxaluria after ethylene glycol poisoning.

Authors:  Ludwig Stapenhorst; Albrecht Hesse; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2008-08-12       Impact factor: 3.714

9.  Urinary NAG in children with urolithiasis, nephrocalcinosis, or risk of urolithiasis.

Authors:  Przemyslaw Sikora; Sara Glatz; Bodo B Beck; Ludwig Stapenhorst; Malgorzata Zajaczkowska; Albrecht Hesse; Bernd Hoppe
Journal:  Pediatr Nephrol       Date:  2003-08-13       Impact factor: 3.714

Review 10.  Diagnostic examination of the child with urolithiasis or nephrocalcinosis.

Authors:  Bernd Hoppe; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2008-12-23       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.